BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2444845)

  • 1. A comprehensive programme to reduce the incidence of hepatitis B virus infection and its sequelae in Alaskan natives.
    McMahon BJ; Rhoades ER; Heyward WL; Tower E; Ritter D; Lanier AP; Wainwright RB; Helminiak C
    Lancet; 1987 Nov; 2(8568):1134-6. PubMed ID: 2444845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program.
    McMahon BJ; Bulkow LR; Singleton RJ; Williams J; Snowball M; Homan C; Parkinson AJ
    Hepatology; 2011 Sep; 54(3):801-7. PubMed ID: 21618565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection of primary hepatocellular carcinoma. Screening for primary hepatocellular carcinoma among persons infected with hepatitis B virus.
    Heyward WL; Lanier AP; McMahon BJ; Fitzgerald MA; Kilkenny S; Paprocki TR
    JAMA; 1985 Dec; 254(21):3052-4. PubMed ID: 2414477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study.
    McMahon BJ; Bulkow L; Harpster A; Snowball M; Lanier A; Sacco F; Dunaway E; Williams J
    Hepatology; 2000 Oct; 32(4 Pt 1):842-6. PubMed ID: 11003632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study on universal immunization of newborn infants in an area of hepatitis B virus and primary hepatocellular carcinoma prevalence with a low dose of hepatitis B vaccine.
    Sun TT; Chu YR; Ni ZQ; Lu JH; Huang F; Ni ZP; Pei XF; Yu ZI; Liu GT
    J Cell Physiol Suppl; 1986; 4():83-90. PubMed ID: 3018008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
    Grob PJ
    Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
    Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
    World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary liver cancer in Alaskan natives. 1980-1985.
    Lanier AP; McMahon BJ; Alberts SR; Popper H; Heyward WL
    Cancer; 1987 Oct; 60(8):1915-20. PubMed ID: 2443234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus and the control of hepatocellular carcinoma.
    Blumberg BS
    IARC Sci Publ; 1984; (63):243-61. PubMed ID: 6100273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B vaccination: an important method of preventing HBV-related hepatocellular carcinoma.
    Zanetti A
    Ital J Gastroenterol; 1992 Feb; 24(2):100-2. PubMed ID: 1315589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and compliance of HBV vaccination trial on newborns to prevent hepatocellular carcinoma and 5-year results of its pilot study.
    Sun Z; Zhu Y; Stjernsward J; Hilleman M; Collins R; Zhen Y; Hsia CC; Lu J; Huang F; Ni Z
    Cancer Detect Prev; 1991; 15(4):313-8. PubMed ID: 1665400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
    Yao M; Zhao J; Lu F
    Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis B vaccine and liver cancer].
    Lebossé F; Zoulim F
    Bull Cancer; 2021 Jan; 108(1):90-101. PubMed ID: 33358507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer.
    Chang MH; You SL; Chen CJ; Liu CJ; Lai MW; Wu TC; Wu SF; Lee CM; Yang SS; Chu HC; Wang TE; Chen BW; Chuang WL; Soon MS; Lin CY; Chiou ST; Kuo HS; Chen DS;
    Gastroenterology; 2016 Sep; 151(3):472-480.e1. PubMed ID: 27269245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer prevention by vaccination against hepatitis B.
    Chang MH
    Recent Results Cancer Res; 2009; 181():85-94. PubMed ID: 19213561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of alpha-fetoprotein and hepatitis-B surface antigen in blood spotted on filter paper: use as a screen for hepatocellular carcinoma in Alaska Natives.
    Parkinson AJ; McMahon BJ; Zanis L; Lanier AP; Wainwright RB
    Arctic Med Res; 1996 Jul; 55(3):123-8. PubMed ID: 8885434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital- and community-based screenings for hepatocellular carcinoma in Taiwan.
    Kee KM; Lu SN
    Oncology; 2011; 81 Suppl 1():36-40. PubMed ID: 22212934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of hepatocellular carcinoma by immunization against hepatitis B.
    Zuckerman AJ
    Int Rev Exp Pathol; 1985; 27():59-81. PubMed ID: 3017884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.